Nordic Life Science Days

Nordic Life Science Days | October 13–14, 2025 | Göteborg (SWE)

Nordic countries have long been a hub of innovation in healthcare and biotechnology. Now, as the region accelerates development of biologics and advanced therapies, the importance of reliable CDMO partnerships is more evident than ever. At Nordic Life Science Days 2025, Mabion invites you to explore how our integrated capabilities can help unlock new possibilities in the Scandinavian market.

The global biologics pipeline is expanding at an unprecedented rate, yet manufacturing capacity remains a critical bottleneck. For Nordic biotech innovators, timely access to cGMP production is a decisive factor for advancing therapies to market. Mabion is here to change that.

Our gene-to-cial approach offers a fully integrated suite of services, including cell banking, process development, drug characterization by different analytical methods, GMP manufacturing, and sterile fill & finish. All under one roof. Our experience spans biosimilars, innovative antibodies, recombinant vaccine antigens, and other therapeutic proteins. Our infrastructure includes multiple 10,000 L bioreactors capacity, enabling flexible scale-up from early-phase clinical supply to commercial volumes.

Through collaboration, we can strengthen the European innovation ecosystem, reduce dependency on external markets, and ensure that biologic drugs reach patients faster. Meet Mabion and discover how our tailored solutions can bring your molecule to life.

Learn more at the NLSD 2025 website and meet us in October.